Women with bulimia nervosa exhibit attenuated secretion of glucagon-like peptide 1, pancreatic polypeptide, and insulin in response to a meal

American Journal of Clinical Nutrition

Volumn 94, Issue 4, 2011, Pages 967-972

  Naessén, Sabine ^a   Carlström, Kjell ^a   Holst, Jens J ^b   Hellström, Per M ^c   Hirschberg, Angelica L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; POLYPEPTIDE;

APPETITE; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; BULIMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; MEAL; MUSCLE TONE; PANCREAS SECRETION; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SATIETY; SELF REPORT; SIGNAL TRANSDUCTION; VISUAL ANALOG SCALE;

ADULT; APPETITE REGULATION; BODY MASS INDEX; BULIMIA NERVOSA; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; PANCREATIC POLYPEPTIDE; POSTPRANDIAL PERIOD; PROTEIN PRECURSORS; SWEDEN; TIME FACTORS; YOUNG ADULT;

EID: 80053183722     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.014837     Document Type: Article

References (34)

1. Treasure J, Claudino AM, Zucker N. Eating disorders. Lancet 2010; 375:583-93.
2. Prince AC, Brooks SJ, Stahl D, Treasure J. Systematic review and meta-analysis of the baseline concentrations and physiologic responses of gut hormones to food in eating disorders. Am J Clin Nutr 2009;89: 755-65.
3. Brubaker PL. Minireview: update on incretin biology: focus on glucagon-like peptide-1. Endocrinology 2010;151:1984-9.
4. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998;101:515-20. (Pubitemid 28084232)
5. Näslund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ, Rössner S, Hellström PM. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord 1999;23:304-11. (Pubitemid 29118862)
6. Verdich C, Flint A, Gutzwiller JP, Näslund E, Beglinger C, Hellström PM, Long SJ, Morgan LM, Holst JJ, Astrup A. A meta-analysis of the effect of glucagon-like-peptide 1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 2001;86:4382-9. (Pubitemid 32848563)
7. Bucinskaite V, Tolessa T, Pedersen J, Rydqvist B, Zerihun L, Holst JJ, Hellström PM. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. Neurogastroenterol Motil 2009; 21:978-e78.
8. Lejeune MPGM, Westererp KR, Adam TCM, Luscombe-Marsh ND, Westererp-Plantenga MS. Ghrelin and glucagon-like peptide 1 concentrations, 24 h satiety, and energy and substrate metabolism during a high protein diet and measured in a respiratory chamber. Am J Clin Nutr 2006;83:89-94. (Pubitemid 44699240)
9. Näslund E, King N, Mansten S, Adner N, Holst JJ, Gutniak M, Hellström PM. Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects. Br J Nutr 2004;91:439-46. (Pubitemid 38386908)
10. Ranganath LR, Beety JM, Morgan LM, Wright JW, Howland R, Marks V. Attenuated GLP-1 secretion in obesity: cause or consequence? Gut 1996;38:916-9. (Pubitemid 26231779)
11. Näslund E, Backman L, Holst JJ, Theodorsson E, Hellström PM. Distal small bowel hormones: correlation with fasting antroduodenal motility and gastric emptying. Dig Dis Sci 1998;43:945-52. (Pubitemid 28211450)
12. Tomasik PJ, Sztefko K, Malek A. GLP-1 as a satiety factor in children with eating disorders. Horm Metab Res 2002;34:77-80. (Pubitemid 34208314)
13. Tomasik PJ, Sztefko K, Starzyk J, Rogatko I, Szafran Z. Entero-insular axis in children with anorexia nervosa. Psychoneuroendocrinology 2005;30:364-72. (Pubitemid 40188191)
14. Germain N, Galusca B, Le Roux CW, Bossu C, Ghatei MA, Lang F, Bloom SR, Estour B. Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide-1, ghrelin and leptin. Am J Clin Nutr 2007;85:967-71. (Pubitemid 46557910)
15. Brambilla F, Monteleone P, Maj M. Glucagon-like peptide-1 secretion in bulimia nervosa. Psychiatry Res 2009;169:82-5.
16. Kojima S, Ueno N, Asakawa A, Sagiyama K, Naruo T, Mizuno S, Inui A. A role for pancreatic polypeptide in feeding and body weight regulation. Peptides 2007;28:459-63. (Pubitemid 46176251)
17. Batterham RL, Le Roux CW, Cohen MA, Park AJ, Ellis SM, Patterson M, Frost GS, Ghatei MA, Bloom SR. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 2003;88: 3989-92. (Pubitemid 37034556)
18. Schmidt PT, Näslund E, Grybäck P, Jacobsson H, Holst JJ, Hilsted L, Hellström PM. A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control. J Clin Endocrinol Metab 2005;90:5241-6. (Pubitemid 41262281)
19. Adrian TE, Greenberg GR, Fitzpatrick ML, Bloom SR. Lack of effect of pancreatic polypeptide in the rate of gastric emptying and gut hormone release during breakfast. Digestion 1981;21:214-8. (Pubitemid 11183917)
20. Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M, Fujino MA, Niijima A, Meguid MM, Kasuga M. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003;124:1325-36. (Pubitemid 36531807)
21. Lassmann V, Vague P, Vialettes B, Simon MC. Low plasma concentrations of pancreatic polypeptide in obesity. Diabetes 1980;29: 428-30. (Pubitemid 11018461)
22. Jesudason DR, Monteiro MP, McGowan BM, Neary NM, Park AJ, Philippou E, Small CJ, Frost GS, Ghatei MA, Bloom SR. Low-dose pancreatic polypeptide inhibits food intake in man. Br J Nutr 2007;97: 426-9. (Pubitemid 46662029)
23. Fujimoto S, Inui A, Kiyota N, Seki W, Koide K, Takamiya S, Uemoto M, Nakajima Y, Baba S, Kasuga M. Increased cholecystokinin and pancreatic polypeptide responses to a fat-rich meal in patients with restrictive but not bulimic anorexia nervosa. Biol Psychiatry 1997;41: 1068-70. (Pubitemid 27225995)
24. Kinzig KP, Coughlin JW, Redgrave GW, Moran TH, Guarda AS. Insulin, glucose, and pancreatic polypeptide responses to a test meal in restricting type anorexia nervosa before and after weight restoration. Am J Physiol Endocrinol Metab 2007;292:E1441-6. (Pubitemid 46684614)
25. Casper RC, Pandy GN, Jaspan JB, Rubenstein AH. Hormone and metabolite plasma concentrations after oral glucose in bulimia and healthy controls. Biol Psychiatry 1988;24:663-74.
26. Naessén S, Carlström K, Byström B, Pierre Y, Hirschberg AL. Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women. Psychoneuroendocrinology 2007;32:548-54. (Pubitemid 46756011)
27. Clinton DN, Glant R. The eating disorders spectrum of DSM-IIIR. J Nerv Ment Dis 1992;180:244-50.
28. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
29. Hirschberg AL, Lindholm C, Carlström K, Von Schoultz B. Reduced serum cholecystokinin response to food intake in female athletes. Metabolism 1994;43:217-21.
30. Ørskov C, Rabenhøj L, Wettergren A, Kofod H, Holst JJ. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 1994;43:535-9. (Pubitemid 24096293)
31. Geliebter A, Melton PM, McCray RS, Gallagher DR, Gage D, Hashim SA. Gastric capacity, gastric emptying, and test-meal intake in normal and bulimic women. Am J Clin Nutr 1992;56:656-61.
32. Hirschberg AL. Hormonal regulation of appetite and food intake. Ann Med 1998;30:7-20. (Pubitemid 28154493)
33. Geracioti TD Jr, Liddle RA. Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med 1988;319:683-8.
34. Tamai H, Takemura J, Kobayashi N, Matsubayashi S, Matsukura S, Nakagawa T. Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. Metabolism 1993;42:581-4. (Pubitemid 23141628)